关注
Keivan Golshiri
Keivan Golshiri
Postdoc
在 erasmusmc.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nitric oxide-cGMP signaling in hypertension: current and future options for pharmacotherapy
E Ataei Ataabadi, K Golshiri, A Jüttner, G Krenning, AHJ Danser, ...
Hypertension 76 (4), 1055-1068, 2020
492020
The importance of the nitric oxide‐cGMP pathway in age‐related cardiovascular disease: Focus on phosphodiesterase‐1 and soluble guanylate cyclase
K Golshiri, E Ataei Ataabadi, EC Portilla Fernandez, AH Jan Danser, ...
Basic & clinical pharmacology & toxicology 127 (2), 67-80, 2020
432020
Clinical effects of Rhus coriaria fruits on dyslipidemia in adolescents: a triple-blinded randomized placebo-controlled trial
AM Sabzghabaee, R Kelishadi, K Golshiri, A Ghannadi, S Badri
Medical archives 68 (5), 308, 2014
422014
Vascular ageing features caused by selective DNA damage in smooth muscle cell
E Ataei Ataabadi, K Golshiri, J van der Linden, M de Boer, DJ Duncker, ...
Oxidative Medicine and Cellular Longevity 2021 (1), 2308317, 2021
182021
Enhancement in dissolution rate of piroxicam by two micronization techniques
J Varshosaz, A Khajavinia, M Ghasemlu, E Ataei, K Golshiri, I Khayam
Dissolution Technol 20 (3), 15-23, 2013
172013
Chronic sildenafil treatment improves vasomotor function in a mouse model of accelerated aging
K Golshiri, E Ataei Ataabadi, R Brandt, I van der Pluijm, R de Vries, ...
International Journal of Molecular Sciences 21 (13), 4667, 2020
132020
Selective phosphodiesterase 1 inhibition ameliorates vascular function, reduces inflammatory response, and lowers blood pressure in aging animals
K Golshiri, EA Ataabadi, E Rubio-Beltran, S Dutheil, W Yao, GL Snyder, ...
Journal of Pharmacology and Experimental Therapeutics 378 (2), 173-183, 2021
112021
Soluble guanylate cyclase activator BAY 54–6544 improves vasomotor function and survival in an accelerated ageing mouse model
E Ataei Ataabadi, K Golshiri, AA Jüttner, R de Vries, ...
Aging Cell 21 (9), e13683, 2022
72022
The effects of acute and chronic selective phosphodiesterase 1 inhibition on smooth muscle cell-associated aging features
K Golshiri, EA Ataabadi, AA Jüttner, GL Snyder, RE Davis, A Lin, L Zhang, ...
Frontiers in Pharmacology 12, 818355, 2022
72022
Adiponectin secretion by perivascular adipose tissue supports impaired vasodilation in a mouse model of accelerated vascular smooth muscle cell and adipose tissue aging
AA Jüttner, EA Ataabadi, K Golshiri, R de Vries, IM Garrelds, AHJ Danser, ...
Vascular Pharmacology 154, 107281, 2024
2024
Clinical Impact And Mechanisms Of Non-Atherosclerotic Vascular Aging: The New Kid to be Blocked
SM Jouabadi, EA Ataabadi, K Golshiri, D Bos, BHC Stricker, AHJ Danser, ...
Canadian Journal of Cardiology, 2023
2023
The sGC activator BAY 54-6544 improves vascular function and survival in an accelerated aging model
E Ataei, K Golshiri, I van der Pluijm, J Danser, P Sandner, A Roks
JOURNAL OF TRANSLATIONAL MEDICINE 21 (SUPPL 1), 2023
2023
Soluble Guanylate Cyclase Activator Treatment Improves Vasomotor Function in an Accelerated-Ageing Mouse Model
E Ataei Ataabadi, K Golshiri, R de Vries, RMC Brandt, I Van Der Pluijm, ...
Circulation 144 (Suppl_1), A9317-A9317, 2021
2021
The Effects of Acute and Chronic Selective Phosphodiesterase 1 Inhibition in Associated Smooth Muscle Cell-Specific Aging Features
K Golshiri, E Ataei Ataabadi, R de Vries, L Zhang, S Chalgeri, A Lin, ...
Circulation 144 (Suppl_1), A10955-A10955, 2021
2021
THE EFFECTS OF ITI-214 (A NEW PHOSPHODIESTERASE 1 INHIBITOR) ON VASCULAR AGEING FEATURES ASSOCIATED TO DNA REPAIR RESPONSE IN MICE
K Golshiri, E Ataei, R Van Veghel, GL Snyder, L Zhang, P Li, RE Davis, ...
Journal of Hypertension 39, e67, 2021
2021
DNA REPAIR DEFECT IN SMOOTH MUSCLE CELL REPRODUCES FEATURES OF AGE-RELATED VASCULAR DISEASE IN MICE
EA Ataabadi, K Golshiri, R De Vries, GL Snyder, L Zhang, P Li, RE Davis, ...
Journal of Hypertension 39, e67, 2021
2021
Selective PDE1 inhibition ameliorates vascular function, reduces inflammatory response, and lowers blood pressure in ageing animals
K Golshiri, E Ataei Ataabadi, E Rubio‐Beltran, S Dutheil, W Yao, ...
Journal of Pharmacology and Experimental Therapeutics 378, 173-183, 2021
2021
Central Angiotensin II Mediates Neurogenic Hypertension Through Hif1-Alpha/NMDAR Axis In The Paraventricular Nucleus Of The Hypothalamus (PVN).
N Sharma, AS Haibara, K Katsurada, SS Nandi, KP Patel
HYPERTENSION 76, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–18